Article

Magnesium Sulfate Product Recalled Due to Barcode Mislabeling

Author(s):

Hospira Inc is voluntarily recalling 1 lot of magnesium sulfate in water for injection.

Hospira Inc is voluntarily recalling 1 lot of magnesium sulfate in water for injection.

The FDA reported that an incorrect barcode was found by a customer on the primary bag labeling. While the barcode on the overwrap is correct, the primary container barcode may be mislabeled with a barcode for heparin sodium.

Hospira stated that it had not yet received any reports of adverse effects stemming from the issue.

The recall affects the product that is packaged as 50 mL fill in 100 mL container bags and sold 24 bags per carton. The lot was distributed between September 2015 and November 2015.

The barcode issue could potentially lead to a delay in treatment, which could result in seizures, stroke, cerebral hemorrhage, maternal death, and risks to the fetus.

Hospira is conducting its own investigation to determine the cause of the mislabeling.

The company noted that anyone with the product should stop using it immediately.

Additionally, the FDA encouraged health care providers and patients to report any adverse effects to MedWatch.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit:  Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit:  kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com